Heeraj Bulluck

Dr. Heeraj Bulluck is an Honorary Senior Lecturer at the School of Medicine, University of Leeds, within the Faculty of Medicine and Health. He is a full-time interventional cardiologist based at Leeds General Infirmary, where he contributes to clinical care and academic research in cardiology.

His educational background includes an MBBS completed in Beijing, China, and a PhD from University College London focusing on tissue characterization by cardiovascular magnetic resonance (CMR) in ST-elevation myocardial infarction (STEMI). He completed his cardiology training in the East of England Deanery, with rotations in Norwich, Ipswich, and Cambridge, and pursued advanced fellowship training in complex coronary interventions at the Golden Jubilee Hospital in Glasgow.

Dr. Bulluck's research is centered on understanding and mitigating reperfusion injury in STEMI patients. His work explores the use of CMR for assessing myocardial damage, particularly intramyocardial hemorrhage as a predictor of adverse outcomes. He is also investigating non-contrast-based CMR techniques for risk stratification, aiming to improve long-term prognosis after myocardial infarction. These efforts are conducted under the Leeds Institute of Cardiovascular and Metabolic Medicine.

His research outputs include journal articles, conference papers, and abstracts, though specific titles are not detailed in the current profile. His work bridges clinical cardiology with translational research, emphasizing imaging-based biomarkers and invasive physiological assessments.

Professional Memberships:

• Fellow of the Royal College of Physicians (FRCP)

Dr. Bulluck maintains active engagement with the academic community through platforms such as Google Scholar, ORCID, ResearchGate, LinkedIn, and Twitter. While no formal students or grants are listed, his role as an Honorary Senior Lecturer suggests involvement in teaching, supervision, and collaborative research. He does not appear to be part of a named lab or team, but his affiliation with the Leeds Institute of Cardiovascular and Metabolic Medicine situates him within a broader research network focused on cardiovascular disease mechanisms and interventions.